GUARANTY OF LEASEGuaranty of Lease • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances
FOR V ALUE RECEIVED, and in consideration for, and as an inducement to Oxbridge Development at Crown Pointe, L.C., a Maryland limited liability company, to consent to an assignment by merger of the lease for space at 610 Professional Drive, Gaithersburg, Md. 20879 dated as of June 22, 2001, as amended September 25, 2001 and as further amended in January, 2003 (such amendment being signed by Joseph Angle on behalf of the then tenant on January 21, 2003 and last initialed by Landlord on January 24, 2003) (the "Lease"), in which it is "Landlord" to GLA II Corp., a Delaware corporation (to be renamed TherImmune Research Corporation at the time of the merger) (“Tenant"), a wholly-owned subsidiary of the undersigned and successor in interest by merger to TherImmune Research Corporation, a Maryland corporation, the original tenant under the Lease, the undersigned, whether one or more, jointly and severally do hereby unconditionally guarantee to Landlord (i)l the punctual and full payment of a
Second Amendment to Executive Employment AgreementExecutive Employment Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances
This Second Amendment (the “Amendment”) is made on this 8th day of May, 2007, but as of the 23rd day of February, 2007 by and between Gene Logic Inc., a Delaware corporation (the “Company”), and Philip L. Rohrer, Jr. (the “Executive”).
Service Provider AgreementService Provider Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • California
This Service Provider Agreement (the "Agreement") is entered into as of 01/01/2007 (the "Effective Date") by and between Affymetrix, Inc., having its principal place of business at 3420 Central Expressway, Santa Clara, CA 95051 ("Affymetrix") and Gene Logic Inc., having its principal place of business at 50 West Watkins Mill Road, Gaithersburg, MD, 20878, USA, ("Service Provider"), each a "Party," and together the "Parties" to this Agreement.
Second Amendment to Executive Employment AgreementExecutive Employment Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances
This Second Amendment (the “Amendment”) is made as of the 23rd day of February, 2007 by and between Gene Logic Inc., a Delaware corporation (the “Company”), and V. W. Brinkerhoff, III (the “Executive”).
RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances
Pursuant to the Gene Logic Inc. 1997 Equity Incentive Plan, as amended and restated effective June 1, 2006 (The “Plan”), Gene Logic Inc. (the “Corporation”) hereby grants to the below named Grantee an award {the “Award”} of Restricted Stock on the Grant Date and for the number of shares of Common Stock of the Corporation (the “Restricted Stock”) listed below.
December 5, 2006 Mr. Lany Tiffany Olney, MD. 20832 RE: Extension of Employment Arrangement Dear Larry:Gene Logic Inc • May 10th, 2007 • In vitro & in vivo diagnostic substances
Gene Logic Inc. and you have previously entered into an employment arrangement as detailed in an offer letter dated June 21, 2006. This arrangement was modified' and extended on August 30, 2006. I am now proposing to further extend the term of that employment upon the following conditions:
BiotechAccess AgreementBiotechaccess Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • California
This BiotechAccess Agreement (the "Agreement") is entered into by and between Affymetrix, Inc., having its principal place of business at 3420 Central Expressway, Santa Clara, CA 95051 ("Affymetrix") and Gene Logic Inc. ("Gene Logic"), having its principal place of business at 50 West Watkins Mill Road, Gaithersburg, MD, 20878, USA, each a "Party," and together the "Parties" to this Agreement as of January 1,2007 (the "Effective Date").
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 10th, 2007 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Maryland
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into by and between Gene Logic Inc., a Delaware corporation (the “Company”), and Larry Tiffany (the “Executive”) as of February 1, 2007 (the “Effective Date”).
